Cost Effectiveness Of Linezolid In Central America
NCT01040585 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2012-03-02
Summary
The therapy with Linezolid (LIN) represents better cost-effectiveness vs. Vancomycin (VAN) for the treatment of nosocomial Pneumonia associate to ventilator (VAP).
Conditions
- Ventilator Acquired Pneumonia
Interventions
- DRUG
-
Linezolid
Treatment for VAP as indication approved and as physician criterium.
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Pfizer CT.gov Call Center · Pfizer
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-07-31
- Primary Completion
- 2011-03-31
- Completion
- 2011-03-31
More Related Trials
-
The Effects of Linezolid and Vancomycin on Inflammation and Cellular Signaling Vents
NCT00811980 ·Status: COMPLETED
-
Pharmacokinetic and Pharmacodynamic Evaluation of Linezolid Administered Intravenously in MRSA-positive, Morbidly Obese Patients With Pneumonia
NCT01805284 ·Status: COMPLETED ·Phase: PHASE4
-
Contezolid Acefosamil Versus Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infection
NCT03747497 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy Study of Ceftolozane/Tazobactam to Treat Ventilated Nosocomial Pneumonia (MK-7625A-008)
NCT02070757 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Neutropenic Patients With Fever Who Are Suspected to Have A Gram Positive Infection
NCT00035425 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Telavancin and Vancomycin for Hospital-acquired Pneumonia Due to Methicillin-resistant Staphylococcus Aureus
NCT00107952 ·Status: COMPLETED ·Phase: PHASE3
-
Lung Concentrations of Ceftazidime in Patients With Ventilator-associated Pneumonia
NCT02837835 ·Status: COMPLETED ·Phase: PHASE3
-
New Antibiotic to Treat Pediatric Patients With Infections Due to a Specific Bacteria (Vancomycin-Resistant Enterococcus)
NCT00035854 ·Status: COMPLETED ·Phase: PHASE3
-
Vancomycin Dosage Adjustment for MRSA Infections
NCT03412500 ·Status: UNKNOWN ·Phase: PHASE4
-
Tedizolid Phosphate (TR-701 FA, MK-1986) vs Linezolid for the Treatment of Nosocomial Pneumonia (MK-1986-002)
NCT02019420 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Aerosolised Colistin in Ventilator Associated Pneumonia
NCT02683603 ·Status: COMPLETED ·Phase: PHASE4
-
Antimicrobial Treatment in Patients With Ventilator-associated Tracheobronchitis
NCT03012360 ·Status: TERMINATED ·Phase: PHASE4
-
Short Infusion Versus Prolonged Infusion of Ceftolozane-tazobactam Among Patients with Ventilator Associated-pneumonia
NCT03581370 ·Status: RECRUITING ·Phase: PHASE3
-
Ceftobiprole in Hospital Acquired Pneumonia
NCT00210964 ·Status: COMPLETED ·Phase: PHASE3
-
Linezolid in Healthy Volunteers
NCT03841721 ·Status: UNKNOWN ·Phase: PHASE1
-
Comprehensive Evaluation of a Central Line Simulation Course
NCT01165398 ·Status: COMPLETED
-
Aerosolized Plus Intravenous vs. Intravenous Colistin for VAP Due to Pandrugs-resistant A. Baumannii in Neonates
NCT02806141 ·Status: TERMINATED ·Phase: PHASE3
-
Continuous Infusion of Linezolid Versus Intermittent Dosing in the Treatment of Nosocomial Pneumonia
NCT04531332 ·Status: UNKNOWN ·Phase: NA
-
Model-informed Precision Dosing for Linezolid
NCT06444802 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Nebulized Ceftazidime and Amikacin in Ventilator Associated Pneumonia
NCT00786305 ·Status: COMPLETED ·Phase: PHASE2
-
Aerosolized Vancomycin in Methicillin-Resistant Staphylococcus Aureus Pneumonia Under Mechanical Ventilation
NCT01925066 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of CEM-102 Compared to Linezolid in Acute Bacterial Skin Infections
NCT00948142 ·Status: COMPLETED ·Phase: PHASE2
-
Trial of Colistin Versus Meropenem in Ventilator-associated Pneumonia (VAP) (CR-GNB)
NCT01292031 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Vancomycin Treatment of Infections Due to Staphylococcus Aureus
NCT00862862 ·Status: TERMINATED
-
Use of a Loading Dose of Vancomycin in Pediatric Dosing
NCT01290237 ·Status: TERMINATED ·Phase: NA